Stock Scorer

Generate Biomedicines, Inc. (GENB)

Every figure this model derived for GENB, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 4,714,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 457,415,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 470,253,000 AssetsCurrent 2026-06-30
current liabilities 56,636,000 LiabilitiesCurrent 2026-06-30
equity 456,045,000 StockholdersEquity 2026-06-30
interest expense 337,000 InterestExpenseNonoperating 2026-06-30
ocf -138,332,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 13,538,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 14,633,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up GENB on one particular measure came for.

RatioValue
cash operating margin-846.48
current ratio10.58
current ratio reported8.3
fcf margin-1056.63
interest cover-402.75
operating margin-1002.56
owner earnings margin-1164.71
revenue growth-28.55
revenue growth per share-28.55
rule of 40-1031.11
sbc pct revenue108.09

Everything else this filing tags

112 more elements from GENB's own XBRL that this model has no measure for, newest reading each, largest first. Nothing here is converted, added up or renamed — it is the filing's own element names and the filing's own numbers.

ElementNewestAs of PeriodsUnit
AdditionalPaidInCapitalCommonStock1,261,040,0002026-06-30 4USD
TemporaryEquityLiquidationPreference960,449,0002025-12-31 2USD
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities811,825,0002026-03-31 2USD
RetainedEarningsAccumulatedDeficit-804,994,0002026-06-30 4USD
Assets561,690,0002026-06-30 4USD
LiabilitiesAndStockholdersEquity561,690,0002026-06-30 4USD
CommonStockSharesAuthorized500,000,0002026-06-30 6shares
CashCashEquivalentsAndShortTermInvestments457,400,0002026-06-30 2USD
NetCashProvidedByUsedInFinancingActivities378,312,0002026-06-30 4USD
ProceedsFromIssuanceInitialPublicOffering369,289,0002026-06-30 4USD
StockIssuedDuringPeriodValueNewIssues369,289,0002026-03-31 2USD
MarketableSecuritiesCurrent322,056,0002026-06-30 4USD
PaymentsToAcquireMarketableSecurities321,759,0002026-06-30 4USD
NetCashProvidedByUsedInInvestingActivities-226,623,0002026-06-30 4USD
HeldToMaturitySecuritiesFairValue157,067,0002026-06-30 2USD
OperatingExpenses149,264,0002026-06-30 6USD
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations139,393,0002026-06-30 8USD
NetIncomeLossAvailableToCommonStockholdersBasic-136,450,0002026-06-30 6USD
OperatingIncomeLoss-135,726,0002026-06-30 6USD
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest-129,204,0002026-06-30 6USD
ProfitLoss-128,969,0002026-06-30 6USD
ComprehensiveIncomeNetOfTax-128,936,0002026-06-30 6USD
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-128,888,0002026-06-30 6USD
NetIncomeLoss-128,701,0002026-06-30 8USD
CommonStockSharesIssued128,269,4282026-06-30 4shares
CommonStockSharesOutstanding128,269,4282026-06-30 4shares
ResearchAndDevelopmentExpense122,142,0002026-06-30 8USD
TemporaryEquitySharesAuthorized113,956,7352025-12-31 2shares
Liabilities105,645,0002026-06-30 4USD
ProceedsFromSaleAndMaturityOfMarketableSecurities99,850,0002026-06-30 4USD
WeightedAverageNumberOfDilutedSharesOutstanding96,730,8862026-06-30 6shares
WeightedAverageNumberOfSharesOutstandingBasic96,730,8862026-06-30 6shares
PropertyPlantAndEquipmentGross82,059,0002026-06-30 4USD
ConvertiblePreferredStockSharesIssuedUponConversion69,333,2442026-06-30 3shares
PreferredStockConvertibleSharesIssuable69,333,2442025-12-31 2shares
OperatingLeaseRightOfUseAsset55,074,0002026-06-30 4USD
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment54,754,0002026-06-30 4USD
OperatingLeaseLiabilityNoncurrent47,643,0002026-06-30 4USD
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross36,076,0002026-06-30 6USD
CommonStockCapitalSharesReservedForFutureIssuance31,608,6812026-06-30 4shares
PropertyPlantAndEquipmentNet27,305,0002026-06-30 4USD
GeneralAndAdministrativeExpense27,122,0002026-06-30 6USD
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount24,376,5452026-06-30 4shares
IncreaseDecreaseInAccruedLiabilities-16,888,0002026-06-30 4USD
AllocatedShareBasedCompensationExpense14,633,0002026-06-30 6USD
IncreaseDecreaseInDeferredRevenue-13,538,0002026-06-30 4USD
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect13,357,0002026-06-30 4USD
PrepaidExpenseAndOtherAssetsCurrent12,838,0002026-06-30 4USD
DeferredRevenueCurrent12,168,0002026-06-30 4USD
PreferredStockSharesAuthorized10,000,0002026-03-02 2shares
OperatingLeaseLiabilityCurrent9,875,0002026-06-30 4USD
OtherAssetsNoncurrent9,058,0002026-06-30 4USD
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue8,238,0002026-06-30 6USD
EmployeeRelatedLiabilitiesCurrent7,982,0002026-06-30 4USD
TemporaryEquityDividendsAdjustment7,749,0002026-06-30 6USD
InvestmentIncomeInterest7,542,0002026-06-30 6USD
ProceedsFromMinorityShareholders7,500,0002026-06-30 4USD
NonoperatingIncomeExpense6,838,0002026-06-30 6USD
DepreciationAndAmortization6,497,0002026-06-30 6USD
DepreciationNonproduction6,497,0002026-06-30 6USD
AccountsPayableCurrent5,653,0002026-06-30 4USD
RestrictedCashAndCashEquivalentsNoncurrent4,034,0002026-06-30 4USD
IncreaseDecreaseInOperatingLeaseLiability-3,789,0002026-06-30 4USD
FinanceLeaseLiabilityCurrent3,744,0002026-06-30 4USD
ProceedsFromStockOptionsExercised3,631,0002026-06-30 4USD
OtherLiabilitiesCurrent2,519,0002026-06-30 4USD
IncreaseDecreaseInOtherOperatingAssets2,267,0002026-06-30 4USD
FinanceLeasePrincipalPayments2,108,0002026-06-30 4USD
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities2,100,0002023-06-30 2USD
CapitalExpendituresIncurredButNotYetPaid2,002,0002026-06-30 4USD
IncreaseDecreaseInAccountsPayable1,800,0002026-06-30 4USD
FinanceLeaseLiabilityNoncurrent1,366,0002026-06-30 4USD
AccruedProfessionalFeesCurrent688,0002026-06-30 4USD
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets600,0002023-06-30 2USD
InvestmentIncomeNetAmortizationOfDiscountAndPremium533,0002026-06-30 4USD
StockIssuedDuringPeriodValueStockOptionsExercised414,0002026-06-30 6USD
SegmentReportingOtherItemAmount367,0002026-06-30 6USD
FairValueAdjustmentOfWarrants363,0002026-06-30 6USD
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets310,0002026-06-30 4USD
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest-268,0002026-06-30 6USD
NetIncomeLossAttributableToNoncontrollingInterest-268,0002026-06-30 6USD
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax-235,0002026-06-30 8USD
AccumulatedOtherComprehensiveIncomeLossNetOfTax-129,0002026-06-30 4USD
CommonStockValue128,0002026-06-30 4USD
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months127,0002026-06-30 2USD
IncreaseDecreaseInOtherNoncurrentLiabilities-117,0002026-06-30 4USD
IncomeTaxExpenseBenefit81,0002026-06-30 6USD
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures46,0002025-03-31 2USD
ForeignCurrencyTransactionGainLossBeforeTax-4,0002026-06-30 6USD
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions532026-06-30 2Holding
EarningsPerShareBasic-12026-06-30 6USD/shares
EarningsPerShareDiluted-12026-06-30 6USD/shares
NumberOfOperatingSegments12026-06-30 2Segment
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate12026-06-30 3pure
StockholdersEquityNoteStockSplitConversionRatio112026-02-28 2pure
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate02026-06-30 3pure
CommonStockParOrStatedValuePerShare02026-06-30 6USD/shares
PreferredStockParOrStatedValuePerShare02026-03-02 2USD/shares
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax02025-12-31 2USD
DeferredRevenueNoncurrent02026-06-30 4USD
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel302026-06-30 2USD
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel302026-06-30 2USD
IncreaseDecreaseInAccountsReceivable02026-06-30 4USD
MinorityInterest02026-06-30 4USD
OtherLiabilitiesNoncurrent02026-06-30 4USD
ProceedsFromIssuanceOfConvertiblePreferredStock02026-06-30 4USD
RestrictedCashAndCashEquivalents02026-06-30 4USD
RestrictedCashAndCashEquivalentsAtCarryingValue02026-06-30 4USD
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate02026-06-30 3pure
TemporaryEquityCarryingAmountAttributableToParent02026-06-30 4USD
TemporaryEquitySharesIssued02026-06-30 4shares
TemporaryEquitySharesOutstanding02026-06-30 5shares

What to be careful about

What this model itself distrusts about GENB's figures. Written by the derivation as it ran, not added afterwards.